In­dus­try groups, CVS pick apart FDA's pro­posed path­way for gener­ics to carve out OTC in­di­ca­tions

Phar­ma in­dus­try groups like the As­so­ci­a­tion for Ac­ces­si­ble Med­i­cines (AAM) and PhRMA are rais­ing point­ed ques­tions about an FDA plan to cre­ate a new path­way …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER